Developer docs
API playgroundTry for free, no card

Search company profiles

Sequenex

Full company profile

uuid000a82v

Namestring
Sequenex
Websiteurl
sequenex.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Sequenex is a private SaMD and digital health software vendor founded in 2020, operating with a headcount of 11-50 employees. The company's sole commercial product is the NEX software platform, a regulatory-ready stack purpose-built for connected medical devices including continuous glucose monitors (CGM), biosensors, and wearables. Sequenex positions NEX as a compliance-first foundation that helps MedTech developers avoid re-engineering software for FDA-style regulatory submissions, with embedded safety and security architecture aimed at accelerating product development timelines.

Sequenex serves two customer tiers within MedTech: early-stage startups that need compliant software infrastructure from inception, and growth-stage companies that need to scale regulatory-ready connected devices toward market entry. Customer engagement is horizontally segmented by company stage rather than by clinical vertical, with CGM, biosensors, and wearables named as the priority device categories.

The go-to-market model is channel-led. In May 2026 Sequenex announced a flagship partnership with MedTech Innovator (MTI), the world's largest medical technology accelerator, under which Sequenex provides the NEX platform to the 65 startups selected for MTI's 2026 cohort (the top 4% of 1,835 global applicants) and engages those companies at the Radar Forum, Innovator Summit, and Finals Competitions. Sequenex also provides financial sponsorship to MTI, suggesting the partnership has both commercial and ecosystem-marketing dimensions. Pricing is not publicly disclosed and the revenue model is consistent with subscription or platform licensing, though no specific contract terms or named enterprise customers are available in the source data. Leadership is a two-person public profile — CEO Amy Neckermann and CTO/CXO John Krlin — consistent with a venture-scale company still in early commercialization.

Short descriptiontext

Sequenex provides the NEX software platform, a regulatory-ready foundation for connected medical devices including CGM, biosensors, and wearables, sold primarily to early- and growth-stage MedTech startups via its MedTech Innovator accelerator partnership.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical device software, connected health platforms, SaMD development, regulatory compliance software, digital health solutions
Industry2 codes
PRIMARYHLAGAKAM
Training & Competency Programs for GxP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYBPAHAIAL
Testing, Inspection, Certification & Commissioning (TICx) Technical Services
NAICS code1 code
  • Computer Systems Design Services541512
SIC code1 code
  • Services-Computer Programming Services7371
Product category
Medical Device Software (SaMD)
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Software Platform Licensing
TypeSubscription Recurring
Description

Provides regulatory-ready NEX software platform to MedTech startups, likely through licensing or subscription model embedded in the accelerator partnership

businesswire.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Sequenex develops and licenses the NEX software platform, a regulatory-ready software solution for connected medical devices including continuous glucose monitors (CGM), biosensors, and wearables. The platform is designed to help early- and growth-stage MedTech companies build, scale, and achieve regulatory compliance for their connected device software faster than developing in-house.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Sequenex offers the NEX software platform as its core product — a regulatory-ready software solution for connected medical devices. The platform specifically supports continuous glucose monitoring (CGM) devices, biosensors, and wearables, providing scalable and compliant software development capabilities for early- and growth-stage MedTech companies.

Product and service1 record
1NEX Software Platform
CategoryMedical Device Software (SaMD)
Description

Regulatory-ready software platform for connected medical devices, including continuous glucose monitors (CGM), biosensors, and wearables, designed to support early- and growth-stage MedTech companies with compliant, scalable software development.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-04
Description

Sequenex partnered with MedTech Innovator, the world's largest medical technology accelerator, to support early- and growth-stage MedTech companies. Under the partnership, Sequenex provides its regulatory-ready NEX software platform for connected medical devices including CGM, biosensors, and wearables, while also providing financial support to MTI. Sequenex engages with cohort companies at critical inflection points throughout the year, including the Radar Forum, Innovator Summit, and Finals Competitions in October.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Industry-standard cloud software for life sciences, with expanding footprint in medical device and clinical operations. A potential incumbent threat as it extends into MedTech regulatory workflows.

TypeDirect peer
Description

Quality management system (QMS) and product lifecycle software purpose-built for medical device companies, including connected devices. Competes with Sequenex in regulatory and compliance enablement for MedTech.

TypeDirect peer
Description

Provides a regulated digital health platform for biopharma and medtech companies building connected drug delivery, medical devices, and combination products. Closest direct competitor to Sequenex in regulated software infrastructure for connected medical devices.

TypeEmerging player
Description

Cloud-based QMS and compliance platform with dedicated medical device capabilities. Targets similar MedTech compliance use cases as Sequenex from a broader enterprise quality angle.

TypeBroad incumbent
Description

Established quality and manufacturing software platform for life sciences and medical device companies, offering regulatory compliance and QMS tools at greater scale than Sequenex.

TypeBroad incumbent
Description

Global life sciences technology and services provider with a regulated platform layer for connected health and medical devices. Competes indirectly as a scaled alternative.

TypeEmerging player
Description

Cloud QMS platform focused on life sciences startups and mid-market medical device companies. Closely comparable to Sequenex in targeting early- and growth-stage MedTech.

TypeBroad incumbent
Description

Clinical trial and digital health platform serving biopharma and medical device developers. Overlaps with Sequenex in regulated software infrastructure for clinical-stage connected devices.

TypeBroad incumbent
Description

Enterprise cloud platform for connected health devices and patient data, including regulated device enablement. Represents the type of large incumbent Sequenex must differentiate against.

10Forma Medical Affairs (Regulatory Software Division)
TypeRegional player
Description

Regulatory and quality software services for medical device companies, with a more consulting-led model. Comparable as a regulatory-software peer for connected medical devices.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sequenex

Medical Device Software (SaMD)sequenex.com

Sequenex provides the NEX software platform, a regulatory-ready foundation for connected medical devices including CGM, biosensors, and wearables, sold primarily to early- and growth-stage MedTech startups via its MedTech Innovator accelerator partnership.

What Sequenex does

Sequenex is a private SaMD and digital health software vendor founded in 2020, operating with a headcount of 11-50 employees. The company's sole commercial product is the NEX software platform, a regulatory-ready stack purpose-built for connected medical devices including continuous glucose monitors (CGM), biosensors, and wearables. Sequenex positions NEX as a compliance-first foundation that helps MedTech developers avoid re-engineering software for FDA-style regulatory submissions, with embedded safety and security architecture aimed at accelerating product development timelines.

Sequenex serves two customer tiers within MedTech: early-stage startups that need compliant software infrastructure from inception, and growth-stage companies that need to scale regulatory-ready connected devices toward market entry. Customer engagement is horizontally segmented by company stage rather than by clinical vertical, with CGM, biosensors, and wearables named as the priority device categories.

The go-to-market model is channel-led. In May 2026 Sequenex announced a flagship partnership with MedTech Innovator (MTI), the world's largest medical technology accelerator, under which Sequenex provides the NEX platform to the 65 startups selected for MTI's 2026 cohort (the top 4% of 1,835 global applicants) and engages those companies at the Radar Forum, Innovator Summit, and Finals Competitions. Sequenex also provides financial sponsorship to MTI, suggesting the partnership has both commercial and ecosystem-marketing dimensions. Pricing is not publicly disclosed and the revenue model is consistent with subscription or platform licensing, though no specific contract terms or named enterprise customers are available in the source data. Leadership is a two-person public profile — CEO Amy Neckermann and CTO/CXO John Krlin — consistent with a venture-scale company still in early commercialization.

Sequenex firmographics

Firmographics
Name
Sequenex
Website
https://sequenex.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Sequenex provides the NEX software platform, a regulatory-ready foundation for connected medical devices including CGM, biosensors, and wearables, sold primarily to early- and growth-stage MedTech startups via its MedTech Innovator accelerator partnership.
Ownership category
akta.pro rank

Sequenex industry classification

Industry
Product category
Medical Device Software (SaMD)
NAICS
Computer Systems Design Services (541512)
SIC
Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLAGAKAM
Training & Competency Programs for GxP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYBPAHAIAL
Testing, Inspection, Certification & Commissioning (TICx) Technical Services

Keywords

  • Medical device software
  • Connected health platforms
  • SaMD development
  • Regulatory compliance software
  • Digital health solutions

Where Sequenex is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Markets served

Sequenex business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Software Platform Licensing: Provides regulatory-ready NEX software platform to MedTech startups, likely through licensing or subscription model embedded in the accelerator partnership

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Sequenex product offering

Product offering

Core offering

Sequenex develops and licenses the NEX software platform, a regulatory-ready software solution for connected medical devices including continuous glucose monitors (CGM), biosensors, and wearables. The platform is designed to help early- and growth-stage MedTech companies build, scale, and achieve regulatory compliance for their connected device software faster than developing in-house.

Product overview

Sequenex offers the NEX software platform as its core product — a regulatory-ready software solution for connected medical devices. The platform specifically supports continuous glucose monitoring (CGM) devices, biosensors, and wearables, providing scalable and compliant software development capabilities for early- and growth-stage MedTech companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • NEX Software Platform Regulatory-ready software platform for connected medical devices, including continuous glucose monitors (CGM), biosensors, and wearables, designed to support early- and growth-stage MedTech companies with compliant, scalable software development.

Companies that use Sequenex

Customer profile

Segments2 records

Ideal customer profiles2 records

Sequenex technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Sequenex partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • MedTech Innovator (MTI)flagshipStrategic or Co-development Partner · 4 May 2026Sequenex partnered with MedTech Innovator, the world's largest medical technology accelerator, to support early- and growth-stage MedTech companies. Under the partnership, Sequenex provides its regulatory-ready NEX software platform for connected medical devices including CGM, biosensors, and wearables, while also providing financial support to MTI. Sequenex engages with cohort companies at critical inflection points throughout the year, including the Radar Forum, Innovator Summit, and Finals Competitions in October.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Sequenex competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Industry-standard cloud software for life sciences, with expanding footprint in medical device and clinical operations. A potential incumbent threat as it extends into MedTech regulatory workflows.
  • MasterControl: Established quality and manufacturing software platform for life sciences and medical device companies, offering regulatory compliance and QMS tools at greater scale than Sequenex.
  • IQVIA: Global life sciences technology and services provider with a regulated platform layer for connected health and medical devices. Competes indirectly as a scaled alternative.
  • Medidata Solutions (Dassault Systèmes): Clinical trial and digital health platform serving biopharma and medical device developers. Overlaps with Sequenex in regulated software infrastructure for clinical-stage connected devices.
  • Philips HealthSuite: Enterprise cloud platform for connected health devices and patient data, including regulated device enablement. Represents the type of large incumbent Sequenex must differentiate against.

Direct peers

  • Greenlight Guru: Quality management system (QMS) and product lifecycle software purpose-built for medical device companies, including connected devices. Competes with Sequenex in regulatory and compliance enablement for MedTech.
  • BrightInsight: Provides a regulated digital health platform for biopharma and medtech companies building connected drug delivery, medical devices, and combination products. Closest direct competitor to Sequenex in regulated software infrastructure for connected medical devices.

Emerging players

  • ComplianceQuest: Cloud-based QMS and compliance platform with dedicated medical device capabilities. Targets similar MedTech compliance use cases as Sequenex from a broader enterprise quality angle.
  • Qualio: Cloud QMS platform focused on life sciences startups and mid-market medical device companies. Closely comparable to Sequenex in targeting early- and growth-stage MedTech.

Regional players

  • Forma Medical Affairs (Regulatory Software Division): Regulatory and quality software services for medical device companies, with a more consulting-led model. Comparable as a regulatory-software peer for connected medical devices.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

Sequenex social profiles

Digital presence

Sequenex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sequenex leadership team

Management profile

Number of profiles

Profiles2 records

Sequenex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sequenex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sequenex

What does Sequenex do?

Sequenex develops and licenses the NEX software platform, a regulatory-ready software solution for connected medical devices including continuous glucose monitors (CGM), biosensors, and wearables. The platform is designed to help early- and growth-stage MedTech companies build, scale, and achieve regulatory compliance for their connected device software faster than developing in-house.

Is Sequenex a public or private company?

Sequenex is a private company. It is classified as unknown and is currently operating.

When was Sequenex founded?

Sequenex was founded in 2020. It employs 11 to 50 people.

Where is Sequenex based?

Sequenex is headquartered in San Diego, United States, in the North America region.

How does Sequenex make money?

One revenue line is on record: software Platform Licensing.

Who are Sequenex's main competitors?

Broad incumbents on record are Veeva Systems, MasterControl, IQVIA, Medidata Solutions (Dassault Systèmes) and Philips HealthSuite. Direct peers are Greenlight Guru and BrightInsight. Emerging players are ComplianceQuest and Qualio. Forma Medical Affairs (Regulatory Software Division) is listed as a regional player.

Does Sequenex have an API?

No public API is recorded for Sequenex.

What industry is Sequenex in?

Sequenex's product category is Medical Device Software (SaMD). Its primary akta.pro industry code is HLAGAKAM, Training & Competency Programs for GxP Compliance, with a secondary code of BPAHAIAL, Testing, Inspection, Certification & Commissioning (TICx) Technical Services. Its NAICS code is 541512 and its SIC code is 7371.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Financial PostSequenex Renews ISO 13485:2016 Quality Management System CertificationSequenex Corp. renewed its ISO 13485:2016 quality management system certification, valid through July 9, 2029, covering software design and development for medical devices. The renewal follows an independent assessment and confirms continued conformity with the standard. The certification supports Sequenex's role as an integrated software partner for medical device companies.FinancialContent Business PageSequenex Renews ISO 13485:2016 Quality Management System CertificationSequenex Corp. renewed its ISO 13485:2016 quality management system certification, valid through July 9, 2029, covering software design and development for medical devices. The renewal follows an independent assessment confirming continued conformity with the standard. The certification supports Sequenex's role as a software partner for medical device companies.AInvestA certificate is not a moatSequenex, a private Atlanta medtech firm, renewed its ISO 13485:2016 certification for medical device software through 2029. The certificate verifies quality processes, not product safety, and reflects rising regulatory demands on software-driven devices. The firm remains private, with listed companies like Dexcom and Abbott absorbing software costs and risks.BioSpaceSequenex Announces Partnership with MedTech Innovator, Industry’s Leading Startup AcceleratorSequenex announced a partnership with MedTech Innovator (MTI), the world's largest medical technology accelerator, through which Sequenex will support early- and growth-stage MedTech companies by providing scalable, regulatory-ready software solutions for connected medical devices including CGM, biosensors, and wearables. MedTech Innovator received a record-setting 1,800 applications for its 2026 program, with 65 startups selected for participation. As a partner, Sequenex will engage with MTI at critical inflection points throughout the year, culminating in Finals Competitions in October.Financial PostSequenex Announces Partnership with MedTech Innovator, Industry's Leading Startup AcceleratorSequenex announced a partnership with MedTech Innovator (MTI), the world's largest accelerator of medical technology companies, to support early- and growth-stage medtech startups. Under the partnership, Sequenex will provide scalable, regulatory-ready software solutions for connected medical devices including CGM, biosensors, and wearables, while also providing financial support to MTI. MedTech Innovator will select 65 startups for its 2026 program from a record 1,800 applications, with the program culminating in Finals Competitions in October.AijournSequenex Announces Partnership with MedTech Innovator, Industry’s Leading Startup AcceleratorSequenex announced a partnership with MedTech Innovator, the world's largest medical technology accelerator, to support early- and growth-stage medtech companies with regulatory-ready software solutions for connected medical devices. As a partner, Sequenex will provide financial support and work directly with select startups selected for MTI's 2026 program, which received a record 1,800 applications and will select 65 startups. The collaboration aims to accelerate development timelines and regulatory readiness by leveraging Sequenex's prebuilt, customizable NEX platform for CGM, biosensors, and wearables.Business Wire BlogSequenex Announces Partnership with MedTech Innovator, Industry’s Leading Startup AcceleratorSequenex announced a partnership with MedTech Innovator (MTI), the world's largest accelerator for medical technology companies, to support early- and growth-stage MedTech startups. Under the agreement, Sequenex will provide financial support and work with selected startups by offering its regulatory-ready NEX software platform for connected medical devices including CGM, biosensors, and wearables. MTI received a record-setting 1,800 applications for its 2026 program and will select 65 startups to participate.YahooSequenex Announces Partnership with MedTech Innovator, Industry’s Leading Startup AcceleratorSequenex announced a partnership with MedTech Innovator (MTI), the world’s largest medical technology accelerator, through which Sequenex will provide scalable, regulatory-ready software solutions for connected medical devices to select early-stage medtech companies in MTI’s 2026 program. Sequenex will also provide financial support to MTI and engage with cohort companies at critical inflection points throughout the year, including the Radar Forum and Innovator Summit. MTI received a record 1,800 applications for its 2026 program and will select 65 startups to participate.PharmiWeb.comSequenex Announces Partnership with MedTech Innovator, Industry’s Leading Startup AcceleratorSequenex announced a partnership with MedTech Innovator (MTI), the world's largest medical technology accelerator, to support early- and growth-stage medtech companies with regulatory-ready software solutions for connected medical devices. Under the partnership, Sequenex will work directly with select emerging companies and provide financial support to MTI's 2026 program, contributing its NEX platform and expertise in compliant software development. MedTech Innovator received a record-setting 1,800 applications for this year's program, with the 2026 accelerator launching at an invite-only summit in San Francisco on June 3–4.MediumWearable Medical Devices: Four Strategic Use Cases Driving the Next Wave of InnovationThe article outlines four strategic use cases for wearable medical devices—monitoring, screening, detection, and prediction—to guide medical device companies in digital health innovation. It highlights the operational benefits of these technologies, such as shifting care from reactive to proactive models, while emphasizing the necessity of integrating data into robust software platforms and navigating SaMD regulatory pathways. Sequenex is presented as a partner helping leaders build these ecosystems to capture market share in value-based care.